Executive Conference Corporation
The mission of ECC Webinars is to provide the pharmaceutical, biotech, and medical device industries with leading edge and informative webinars led by experts in their fields, fostering a stronger knowledge base in the workforce.
"The Difference is Distictive"
Webinars
Archived ECC Webinars
| ECC # | DATE | TITLE | Instructor(s) |
|---|---|---|---|
| ECC-631 | 2024-11-20 | Cleaning Validation Analytical Methods: Frequently Asked Questions | Paul Lopolito,Brian Bosso |
| ECC-647 | 2024-11-19 | Good Laboratory Practices (GLP) vs. Good Manufacturing Practices (GMPs) — A Comparison and Contrast – “Why One Should Use Only GMP Facilities for Manufacturing and Testing” | Barry A. Friedman Ph.D |
| ECC-646 | 2024-11-14 | Managing Microbiological Out of Specification (OOS) and Out of Trend (OOT) Results in Sterile and Non-Sterile ProductionFDA and ICH Expectations and Guidance | Barry A. Friedman Ph.D |
| ECC-645 | 2024-11-13 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-650 | 2024-11-12 | GMP Environmental Monitoring for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-649 | 2024-11-07 | Quality System Management Effectiveness | Danielle DeLucy |
| ECC-651 | 2024-11-05 | Hot Topics in the Cleanroom Industry: Biodecontamination of RABS and Isolators, Materials Transfer and Disinfectant Field Trials | Jim Polarine |
| ECC-630 | 2024-10-30 | Establishing Limits for Cleaning Validation | Paul Lopolito,Dijana Hadziselimovic |
| ECC-640 | 2024-10-29 | The Microbiology of Water in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-642 | 2024-10-16 | CAPA/Root Cause Analysis: Achieving Compliance with Proper CAPA Systems | Danielle DeLucy |
| ECC-643 | 2024-10-15 | A Roadmap to a Successful Contamination Control Strategy (CCS): Covering Annex I Updates and FDA Warning Letters and 483’s | Jim Polarine |
| ECC-639 | 2024-10-09 | FDA Contract Manufacturing Arrangements for Drugs: Quality Agreements - Their Relationship to Microbiological Issues | Barry A. Friedman Ph.D |
| ECC-644 | 2024-10-08 | HVAC and GMP Environmental Control – for Pharmaceutical Clean Rooms | Roger Cowan |
| ECC-641 | 2024-10-03 | Investigating OOS results | Danielle DeLucy |
| ECC-638 | 2024-10-02 | Annual Laboratory Microbiology Training | Barry A. Friedman Ph.D |
| ECC-637 | 2024-10-01 | Bioburden Control of Non-Sterile Drug Substances and Products– A New USP General Information Chapter | Barry A. Friedman Ph.D |
| ECC-636 | 2024-09-26 | Process Simulation Testing for Aseptically Filled Products | Barry A. Friedman Ph.D |
| ECC-629 | 2024-09-25 | How to Remediate Microbial Contamination of Process Equipment | Paul Lopolito,Brian Bosso |
| ECC-635 | 2024-09-24 | VALIDATION MASTER PLANNING (DEVELOPING A COMPREHENSIVE VALIDATION PACKAGE) | Barry A. Friedman Ph.D |
| ECC-634 | 2024-09-17 | A Risk Assessment Approach to Address Fungal Spore Contamination in a Cell and Gene Therapy Cleanroom | Jim Polarine |
| ECC-633 | 2024-09-05 | TERMINALLY STERILIZED PHARMACEUTICAL PRODUCTS—PARAMETRIC RELEASE (NEW USP<1222>, November 2019) AND ITS RELATIONSHIP TO THE NEW BRITISH TERMINAL STERILIZATION METHODOLOGY (March 2019) | Barry A. Friedman Ph.D |
| ECC-632 | 2024-09-04 | Pharmaceutical Compressed Air – Quality GMP Standards and Requirements | Roger Cowan |
| ECC-628 | 2024-08-28 | Derouging and Passivation of Stainless-Steel Equipment | Paul Lopolito,Dijana Hadziselimovic |
| ECC-627 | 2024-08-27 | Risk Management of Raw Materials in a GMP Environment | Barry A. Friedman Ph.D |
| ECC-625 | 2024-08-22 | Effective Batch Record Review | Danielle DeLucy |
| ECC-624 | 2024-08-21 | THE BACTERIAL ENDOTOXINS TEST (ISSUES AND SOLUTIONS) TO INCLUDE THE ISSUE OF LOW ENDOTOXIN RECOVERY (LER) AND TR 82 (PDA) AND GENERAL INFORMATION CHAPTER <1085> | Barry A. Friedman Ph.D |
| ECC-626 | 2024-08-15 | Development of a Steam Autoclave Sterilization Validation Plan | Barry A. Friedman Ph.D |
| ECC-622 | 2024-08-13 | Hot Topics in the Cleanroom Industry, Biodecontamination of RABS and Isolators, Materials Transfer and Disinfectant Field Trials | Jim Polarine |
| Page: | 1 | | |||